The existence of a relationship between increased serum alanine aminotransferase levels detected in premarketing clinical trials and postmarketing published hepatotoxicity case reports.

Llanos, L; Moreu, R; Ortin, T; Peiró, A M; Pascual, S; Bellot, P; Barquero, C; Francés, R; Such, J; Pérez-Mateo, M; Horga, J F; Zapater, P

Llanos, L; Moreu, R; Ortin, T; Peiró, A M; Pascual, S; Bellot, P; Barquero, C; Francés, R; Such, J; Pérez-Mateo, M; Horga, J F; Zapater, P.

Affiliation

Llanos L; Clinical Pharmacology Section, Hospital General Universitario, Alicante, Spain.

Aliment Pharmacol Ther ; 31(12): 1337-45, 2010 Jun.

Article in En | MEDLINE | ID: mdl-20331578

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Alanine Transaminase / Chemical and Drug Induced Liver Injury Type of study: Clinical_trials / Incidence_studies / Prognostic_studies Limits: Humans Language: En Journal: Aliment Pharmacol Ther Journal subject: FARMACOLOGIA / GASTROENTEROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2010 Document type: Article Affiliation country: España Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google